arginine has been researched along with Mesenteric Vascular Occlusion in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Senoh, M; Sunami, K; Yokota, Y; Yoshioka, T | 1 |
| Kostakis, A; Kostakis, M; Liarakos, N; Margaritis, E; Pantopoulou, A; Perrea, D; Poulakou, M; Yanni, AE | 1 |
| Bick, RJ; Desoignie, R; Kozar, RA; Moore, FA; Poindexter, BJ; Sato, N; Schultz, SG; Verner-Cole, E | 1 |
| Kozar, RA; Moore, FA; Moore-Olufemi, S; Sato, N; Schultz, SG; Smith, MA; Zou, L | 1 |
| Eto, T; Gondo, H; Hamasaki, N; Ichimiya, H; Kato, K; Kawamoto, M; Kayamori, Y; Muta, T; Okamura, T; Shibuya, T; Urata, M; Wada, Y; Yamanaka, M | 1 |
| Granger, DN; Horie, Y; Wolf, R | 1 |
6 other study(ies) available for arginine and Mesenteric Vascular Occlusion
| Article | Year |
|---|---|
Successful intravenous administration of argatroban in the management of heparin-resistant and surgery-resistant mesenteric vein thrombosis.
Topics: Administration, Intravenous; Aged; Antithrombins; Arginine; Female; Humans; Mesenteric Vascular Occlusion; Mesenteric Veins; Pipecolic Acids; Portal Vein; Splenic Vein; Sulfonamides; Treatment Outcome; Venous Thrombosis | 2019 |
Time-dependent alterations in serum NO concentration after oral administration of L-arginine, L-NAME, and allopurinol in intestinal ischemia/reperfusion.
Topics: Administration, Oral; Allopurinol; Animals; Arginine; Catalase; Disease Models, Animal; Enzyme Inhibitors; Intestinal Mucosa; Intestines; Male; Mesenteric Artery, Superior; Mesenteric Vascular Occlusion; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Rats; Rats, Wistar; Reperfusion Injury; Time Factors; Xanthine Oxidase | 2008 |
The immune-enhancing enteral agents arginine and glutamine differentially modulate gut barrier function following mesenteric ischemia/reperfusion.
Topics: Actins; Adjuvants, Immunologic; Analysis of Variance; Animals; Arginine; Cell Membrane Permeability; Cytoskeleton; Enteral Nutrition; Glutamine; Intestinal Mucosa; Male; Mesenteric Vascular Occlusion; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2004 |
Immune-enhancing enteral nutrients differentially modulate the early proinflammatory transcription factors mediating gut ischemia/reperfusion.
Topics: Analysis of Variance; Animals; Arginine; Disease Models, Animal; Drug Evaluation, Preclinical; Electrophoretic Mobility Shift Assay; Enteral Nutrition; Glutamine; Immunity, Mucosal; Immunologic Factors; Inflammation; Jejunum; Male; Mesenteric Artery, Superior; Mesenteric Vascular Occlusion; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Patient Selection; Peroxisome Proliferator-Activated Receptors; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Risk Factors; Time Factors; Transcription Factor AP-1 | 2005 |
Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency.
Topics: Adult; Antithrombin III Deficiency; Arginine; DNA Mutational Analysis; Female; Frameshift Mutation; Heterozygote; Humans; Mesenteric Vascular Occlusion; Mesenteric Veins; Pipecolic Acids; Salvage Therapy; Sulfonamides; Treatment Outcome; Venous Thrombosis | 2005 |
Role of nitric oxide in gut ischemia-reperfusion-induced hepatic microvascular dysfunction.
Topics: Alanine Transaminase; Animals; Arginine; Biological Availability; Intestines; Ischemia; Leukocytes; Liver Circulation; Mesenteric Arteries; Mesenteric Vascular Occlusion; Mice; Mice, Inbred C57BL; Microcirculation; NAD; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Triazenes | 1997 |